Related Experiment Video

Updated: Apr 26, 2026

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
04:43

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

Published on: February 27, 2020

6.4K

DNA vaccine elicits an efficient antitumor response by targeting the mutant Kras in a transgenic mouse lung cancer

T-Y Weng1, M-C Yen2, C-T Huang3

  • 11] Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC [2] Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.

Gene Therapy
|August 1, 2014
PubMed

Insights

A novel Kras DNA vaccine shows promise for treating non-small-cell lung cancer with Kras mutations. This immunotherapy effectively reduced tumors and boosted immune responses in preclinical models.

Area of Science:

  • Oncology
  • Immunotherapy
  • Molecular Biology

Background:

  • Mutant Kras (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) drives over 20% of non-small-cell lung cancers.
  • Current therapeutic options targeting Kras mutations are limited.
  • DNA vaccines represent a potential novel immunotherapeutic strategy for Kras-driven cancers.

Purpose of the Study:

  • To investigate the antitumor efficacy of a Kras DNA vaccine in a genetically engineered mouse model of lung cancer.
  • To evaluate the vaccine's impact on immune responses and tumor-infiltrating lymphocytes.
  • To assess the specificity of the Kras DNA vaccine's therapeutic effects.

Main Methods:

  • Kras(G12D)-driven lung tumors were induced in mice using doxycycline.
  • Therapeutic effects were evaluated following administration of Kras(G12D) DNA plasmids.
  • Immune responses, including T-helper 1 responses and CD8+ T cell infiltration, were analyzed.
  • Antigen specificity was assessed using splenocyte assays with Kras, Hras, and OVA peptides.

Main Results:

  • The Kras DNA vaccine significantly reduced tumor nodule formation.
  • A dominant-negative Kras(G12D)N17 mutant plasmid demonstrated comparable therapeutic effects.
  • Enhanced T-helper 1 immune responses and increased tumor-infiltrating CD8+ T cells were observed.
  • Antigen-specific T cell responses were directed against Kras peptides.

Conclusions:

  • The Kras DNA vaccine elicits an effective antitumor immune response in Kras-mutated lung cancer models.
  • The vaccine demonstrates potential as a therapeutic agent for lung cancers harboring Ras mutations.
  • The vaccine's efficacy was specific to Kras-driven tumors, showing no effect in EGFR-mutated lung cancer models.

More Related Videos

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

22.8K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

16.7K

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
4.7K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.8K